

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.92785367 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.92785367 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.59381157 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.59381157 |
| 5 | hemoglobin metabolic process (GO:0020027) | 6.32387059 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.00209956 |
| 7 | oxygen transport (GO:0015671) | 5.91207983 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.76826057 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.48907479 |
| 10 | gas transport (GO:0015669) | 5.25159636 |
| 11 | high-density lipoprotein particle remodeling (GO:0034375) | 5.22887250 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.20673744 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.20673744 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.20673744 |
| 15 | cysteine metabolic process (GO:0006534) | 5.20411072 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.18059270 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.16484269 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.13506126 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.01443037 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.00265946 |
| 21 | tryptophan metabolic process (GO:0006568) | 4.97780403 |
| 22 | regulation of fibrinolysis (GO:0051917) | 4.90573532 |
| 23 | urea cycle (GO:0000050) | 4.80246475 |
| 24 | urea metabolic process (GO:0019627) | 4.80246475 |
| 25 | protein carboxylation (GO:0018214) | 4.75875821 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.75875821 |
| 27 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.72910070 |
| 28 | reverse cholesterol transport (GO:0043691) | 4.72425755 |
| 29 | lysine catabolic process (GO:0006554) | 4.55150087 |
| 30 | lysine metabolic process (GO:0006553) | 4.55150087 |
| 31 | bile acid metabolic process (GO:0008206) | 4.48474595 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.48055199 |
| 33 | complement activation, alternative pathway (GO:0006957) | 4.44099104 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.42476907 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.41426958 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.40106670 |
| 37 | heme biosynthetic process (GO:0006783) | 4.38780626 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.38377991 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.37254005 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.37254005 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.37254005 |
| 42 | phospholipid efflux (GO:0033700) | 4.36817022 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.36280849 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 4.36122916 |
| 45 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.36037374 |
| 46 | porphyrin-containing compound metabolic process (GO:0006778) | 4.35807074 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.30195405 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.30195405 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.25793514 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.25793514 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.24188657 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 4.21521625 |
| 53 | plasma lipoprotein particle assembly (GO:0034377) | 4.18716663 |
| 54 | cellular modified amino acid catabolic process (GO:0042219) | 4.18340752 |
| 55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.18218753 |
| 56 | regulation of complement activation (GO:0030449) | 4.16528490 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.13844035 |
| 58 | coenzyme catabolic process (GO:0009109) | 4.12432427 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.10006132 |
| 60 | erythrocyte development (GO:0048821) | 4.05532457 |
| 61 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.04617210 |
| 62 | tetrapyrrole biosynthetic process (GO:0033014) | 4.03500848 |
| 63 | cholesterol efflux (GO:0033344) | 3.97022285 |
| 64 | regulation of response to osmotic stress (GO:0047484) | 3.96240961 |
| 65 | iron ion import (GO:0097286) | 3.95481834 |
| 66 | heme metabolic process (GO:0042168) | 3.95164141 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 3.95030265 |
| 68 | bile acid and bile salt transport (GO:0015721) | 3.93216750 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 3.93137386 |
| 70 | ethanol oxidation (GO:0006069) | 3.92203526 |
| 71 | intestinal cholesterol absorption (GO:0030299) | 3.91538495 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 3.86436052 |
| 73 | glutamate metabolic process (GO:0006536) | 3.82443308 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 3.82289663 |
| 75 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.77131793 |
| 76 | glycine metabolic process (GO:0006544) | 3.70025561 |
| 77 | protein-lipid complex assembly (GO:0065005) | 3.69556535 |
| 78 | erythrocyte maturation (GO:0043249) | 3.68174854 |
| 79 | plasma lipoprotein particle organization (GO:0071827) | 3.62292216 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 3.61579039 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 3.61513769 |
| 82 | ketone body metabolic process (GO:1902224) | 3.60996022 |
| 83 | response to methylmercury (GO:0051597) | 3.60596020 |
| 84 | negative regulation of protein activation cascade (GO:2000258) | 3.57952184 |
| 85 | cofactor catabolic process (GO:0051187) | 3.55468221 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 3.55176125 |
| 87 | amine catabolic process (GO:0009310) | 3.51810662 |
| 88 | cellular biogenic amine catabolic process (GO:0042402) | 3.51810662 |
| 89 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51200614 |
| 90 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51200614 |
| 91 | arginine metabolic process (GO:0006525) | 3.49484624 |
| 92 | drug catabolic process (GO:0042737) | 3.49307924 |
| 93 | carboxylic acid catabolic process (GO:0046395) | 3.44731180 |
| 94 | organic acid catabolic process (GO:0016054) | 3.44731180 |
| 95 | short-chain fatty acid metabolic process (GO:0046459) | 3.43972095 |
| 96 | negative regulation of lipase activity (GO:0060192) | 3.42135257 |
| 97 | fibrinolysis (GO:0042730) | 3.42099741 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.41468491 |
| 99 | negative regulation of complement activation (GO:0045916) | 3.41206845 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.41085807 |
| 101 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.39096807 |
| 102 | cellular glucuronidation (GO:0052695) | 3.38382961 |
| 103 | protein-lipid complex subunit organization (GO:0071825) | 3.37387912 |
| 104 | serine family amino acid biosynthetic process (GO:0009070) | 3.36655836 |
| 105 | positive regulation of extracellular matrix organization (GO:1903055) | 3.36187400 |
| 106 | low-density lipoprotein particle clearance (GO:0034383) | 3.36047635 |
| 107 | valine metabolic process (GO:0006573) | 3.35535007 |
| 108 | heme transport (GO:0015886) | 3.34659851 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.33926792 |
| 110 | regulation of apoptotic cell clearance (GO:2000425) | 3.31757311 |
| 111 | linoleic acid metabolic process (GO:0043651) | 3.29188881 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.28798931 |
| 113 | aspartate family amino acid catabolic process (GO:0009068) | 3.28118499 |
| 114 | phospholipid homeostasis (GO:0055091) | 3.27182512 |
| 115 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.26371818 |
| 116 | sterol homeostasis (GO:0055092) | 3.23560531 |
| 117 | drug transmembrane transport (GO:0006855) | 3.22350379 |
| 118 | 2-oxoglutarate metabolic process (GO:0006103) | 3.20865854 |
| 119 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.19659019 |
| 120 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15191693 |
| 121 | positive regulation of receptor recycling (GO:0001921) | 3.04506625 |
| 122 | macroautophagy (GO:0016236) | 3.01749031 |
| 123 | positive regulation of hemostasis (GO:1900048) | 2.96032299 |
| 124 | positive regulation of blood coagulation (GO:0030194) | 2.96032299 |
| 125 | regulation of extracellular matrix disassembly (GO:0010715) | 2.91887081 |
| 126 | negative regulation of humoral immune response (GO:0002921) | 2.90984436 |
| 127 | creatine metabolic process (GO:0006600) | 2.88744946 |
| 128 | regulation of plasminogen activation (GO:0010755) | 2.83190534 |
| 129 | positive regulation of coagulation (GO:0050820) | 2.83150932 |
| 130 | ethanol metabolic process (GO:0006067) | 2.83096618 |
| 131 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.79353684 |
| 132 | regulation of cholesterol metabolic process (GO:0090181) | 2.72179639 |
| 133 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.71398240 |
| 134 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.70723829 |
| 135 | basement membrane organization (GO:0071711) | 2.70624531 |
| 136 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.69526315 |
| 137 | hypotonic response (GO:0006971) | 2.68263573 |
| 138 | myeloid cell development (GO:0061515) | 2.67203303 |
| 139 | melanin biosynthetic process (GO:0042438) | 2.63601323 |
| 140 | response to mercury ion (GO:0046689) | 2.61474153 |
| 141 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.60319780 |
| 142 | detection of molecule of bacterial origin (GO:0032490) | 2.60267246 |
| 143 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.59920434 |
| 144 | regulation of extracellular matrix organization (GO:1903053) | 2.58304192 |
| 145 | negative regulation of fatty acid transport (GO:2000192) | 2.58200241 |
| 146 | modulation by virus of host process (GO:0019054) | 2.52990951 |
| 147 | tetrapyrrole metabolic process (GO:0033013) | 2.49639641 |
| 148 | modulation by symbiont of host cellular process (GO:0044068) | 2.48905178 |
| 149 | cellular response to epinephrine stimulus (GO:0071872) | 2.41360194 |
| 150 | cellular response to virus (GO:0098586) | 2.38921968 |
| 151 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.38680532 |
| 152 | positive regulation of fibroblast migration (GO:0010763) | 2.36461412 |
| 153 | erythrocyte differentiation (GO:0030218) | 2.36401724 |
| 154 | protein activation cascade (GO:0072376) | 2.33841353 |
| 155 | regulation of humoral immune response (GO:0002920) | 2.30494544 |
| 156 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.29630062 |
| 157 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.29174378 |
| 158 | mitochondrion degradation (GO:0000422) | 2.27767757 |
| 159 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.27277172 |
| 160 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.25965476 |
| 161 | melanin metabolic process (GO:0006582) | 2.25737414 |
| 162 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.25132954 |
| 163 | acute-phase response (GO:0006953) | 2.24518159 |
| 164 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.22489435 |
| 165 | regulation of receptor recycling (GO:0001919) | 2.21844082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.88136356 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.76034283 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.09730558 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.75907670 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.17092547 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.65486465 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.53568625 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.77158655 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.45985602 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.10411228 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.52422319 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.25976455 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07961755 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02614633 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01054205 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9811526 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.99381812 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98152297 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74518774 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74025000 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.71805412 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69639568 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65013599 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56347641 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56125404 |
| 26 | GATA1_19941826_ChIP-Seq_K562_Human | 1.54885099 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50016057 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48283533 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.45902850 |
| 30 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.39218922 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38195424 |
| 32 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.37832745 |
| 33 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.32864103 |
| 34 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.32864103 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32528484 |
| 36 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31817167 |
| 37 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31106327 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30145413 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30075739 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29889288 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26917089 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26657365 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26099213 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25263460 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24513005 |
| 46 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24370876 |
| 47 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22279518 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18353518 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17919428 |
| 50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16198632 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15898036 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12606933 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12480089 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12354408 |
| 55 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11549477 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11406488 |
| 57 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11149444 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09896017 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07358410 |
| 60 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06882382 |
| 61 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06755001 |
| 62 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06552969 |
| 63 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06463839 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05388410 |
| 65 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05040069 |
| 66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04801153 |
| 67 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04779966 |
| 68 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04705491 |
| 69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04350287 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03990040 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03931199 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03846061 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02827607 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02508977 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02167648 |
| 76 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01800391 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00854233 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99569307 |
| 79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97929826 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96992696 |
| 81 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96167545 |
| 82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95842038 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94195426 |
| 84 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92656305 |
| 85 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92418727 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92180674 |
| 87 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91863614 |
| 88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.91520608 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90854214 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.90455935 |
| 91 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89888707 |
| 92 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89180022 |
| 93 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85232093 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83839564 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82714715 |
| 96 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.77496202 |
| 97 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74099774 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.72643092 |
| 99 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70848945 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68117869 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67815305 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66674085 |
| 103 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.65066569 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.64965935 |
| 105 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.64903684 |
| 106 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.64630350 |
| 107 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.64399254 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.64381535 |
| 109 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63194753 |
| 110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.63022365 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62881189 |
| 112 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.62268244 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.61635285 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61208228 |
| 115 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.60704662 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60680770 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60566204 |
| 118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60532122 |
| 119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.59415276 |
| 120 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.58028552 |
| 121 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57997920 |
| 122 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56940985 |
| 123 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.55162784 |
| 124 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.55048740 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.54415010 |
| 126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.53408346 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53336088 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.53235870 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.53235870 |
| 130 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50903914 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50660920 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.50658348 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.50502886 |
| 134 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.50267159 |
| 135 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.49547564 |
| 136 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.49317893 |
| 137 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48633129 |
| 138 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.48020496 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.47300213 |
| 140 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.46822228 |
| 141 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.46798486 |
| 142 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46682505 |
| 143 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.46171499 |
| 144 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.46072729 |
| 145 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.45909249 |
| 146 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.45244979 |
| 147 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.45045331 |
| 148 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.44934800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.11734405 |
| 2 | MP0005360_urolithiasis | 6.37307313 |
| 3 | MP0005365_abnormal_bile_salt | 5.94019672 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.79087037 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.34974466 |
| 6 | MP0005083_abnormal_biliary_tract | 3.85125610 |
| 7 | MP0003252_abnormal_bile_duct | 3.63039846 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.34719960 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.31100724 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.21517580 |
| 11 | MP0009840_abnormal_foam_cell | 3.00117028 |
| 12 | MP0003195_calcinosis | 2.90597087 |
| 13 | MP0008260_abnormal_autophagy | 2.77980461 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.75114360 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.64184193 |
| 16 | MP0005332_abnormal_amino_acid | 2.52303938 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.50676463 |
| 18 | MP0005171_absent_coat_pigmentation | 2.44791217 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.36664691 |
| 20 | MP0003868_abnormal_feces_composition | 2.32981811 |
| 21 | MP0004858_abnormal_nervous_system | 2.13663562 |
| 22 | MP0004381_abnormal_hair_follicle | 2.13314413 |
| 23 | MP0002132_abnormal_respiratory_system | 2.13273097 |
| 24 | MP0000609_abnormal_liver_physiology | 2.10462674 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 2.06797789 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 2.06277734 |
| 27 | MP0005409_darkened_coat_color | 2.04420434 |
| 28 | MP0005220_abnormal_exocrine_pancreas | 1.97110934 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.96587578 |
| 30 | MP0003122_maternal_imprinting | 1.88768888 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.88743019 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.81533431 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.75883110 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.72936140 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.72528854 |
| 36 | MP0000371_diluted_coat_color | 1.62178014 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.58069440 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.57733294 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.56238228 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.54624879 |
| 41 | MP0003878_abnormal_ear_physiology | 1.54624879 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.51586146 |
| 43 | MP0001958_emphysema | 1.47873204 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 1.46252974 |
| 45 | MP0005275_abnormal_skin_tensile | 1.44981096 |
| 46 | MP0001764_abnormal_homeostasis | 1.37318232 |
| 47 | MP0004147_increased_porphyrin_level | 1.36604352 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.34756830 |
| 49 | MP0003011_delayed_dark_adaptation | 1.31198290 |
| 50 | MP0001915_intracranial_hemorrhage | 1.30522067 |
| 51 | MP0004883_abnormal_blood_vessel | 1.24714404 |
| 52 | MP0003123_paternal_imprinting | 1.24681500 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 1.22317486 |
| 54 | MP0001944_abnormal_pancreas_morphology | 1.21202594 |
| 55 | MP0006138_congestive_heart_failure | 1.19753028 |
| 56 | MP0003186_abnormal_redox_activity | 1.18178513 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 1.14691860 |
| 58 | MP0004043_abnormal_pH_regulation | 1.13820165 |
| 59 | MP0005164_abnormal_response_to | 1.10755473 |
| 60 | MP0000598_abnormal_liver_morphology | 1.10309613 |
| 61 | MP0004272_abnormal_basement_membrane | 1.07992667 |
| 62 | MP0004264_abnormal_extraembryonic_tissu | 1.06223775 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.05925438 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.05925438 |
| 65 | MP0002693_abnormal_pancreas_physiology | 1.05186588 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 1.03290258 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.01430042 |
| 68 | MP0003300_gastrointestinal_ulcer | 1.01095596 |
| 69 | MP0002089_abnormal_postnatal_growth/wei | 0.98041991 |
| 70 | MP0004233_abnormal_muscle_weight | 0.97600396 |
| 71 | MP0000749_muscle_degeneration | 0.95553625 |
| 72 | MP0010368_abnormal_lymphatic_system | 0.94157010 |
| 73 | MP0002108_abnormal_muscle_morphology | 0.93651653 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.93161233 |
| 75 | MP0005248_abnormal_Harderian_gland | 0.93128692 |
| 76 | MP0002254_reproductive_system_inflammat | 0.92192792 |
| 77 | MP0009053_abnormal_anal_canal | 0.90988906 |
| 78 | MP0001324_abnormal_eye_pigmentation | 0.90460383 |
| 79 | MP0005647_abnormal_sex_gland | 0.90248526 |
| 80 | MP0003436_decreased_susceptibility_to | 0.89716812 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.87982452 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 0.87428559 |
| 83 | MP0003828_pulmonary_edema | 0.86698921 |
| 84 | MP0005503_abnormal_tendon_morphology | 0.86629206 |
| 85 | MP0002909_abnormal_adrenal_gland | 0.86113933 |
| 86 | MP0002075_abnormal_coat/hair_pigmentati | 0.85961841 |
| 87 | MP0000858_altered_metastatic_potential | 0.85949714 |
| 88 | MP0003279_aneurysm | 0.85839415 |
| 89 | MP0005535_abnormal_body_temperature | 0.84533332 |
| 90 | MP0001186_pigmentation_phenotype | 0.84318389 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.83269223 |
| 92 | MP0001756_abnormal_urination | 0.83235494 |
| 93 | MP0009697_abnormal_copulation | 0.82679615 |
| 94 | MP0000604_amyloidosis | 0.82421596 |
| 95 | MP0003136_yellow_coat_color | 0.81084435 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.79617981 |
| 97 | MP0003303_peritoneal_inflammation | 0.79377139 |
| 98 | MP0001851_eye_inflammation | 0.78772525 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.78641361 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.78628721 |
| 101 | MP0000747_muscle_weakness | 0.78221904 |
| 102 | MP0005334_abnormal_fat_pad | 0.78008181 |
| 103 | MP0000751_myopathy | 0.77839808 |
| 104 | MP0005408_hypopigmentation | 0.76894574 |
| 105 | MP0005670_abnormal_white_adipose | 0.76215347 |
| 106 | MP0003879_abnormal_hair_cell | 0.75745606 |
| 107 | MP0009764_decreased_sensitivity_to | 0.75402125 |
| 108 | MP0009763_increased_sensitivity_to | 0.75319553 |
| 109 | MP0004036_abnormal_muscle_relaxation | 0.74423656 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 0.74343414 |
| 111 | MP0000759_abnormal_skeletal_muscle | 0.73667167 |
| 112 | MP0003724_increased_susceptibility_to | 0.73477757 |
| 113 | MP0002095_abnormal_skin_pigmentation | 0.73260650 |
| 114 | MP0001849_ear_inflammation | 0.72806805 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 0.72466420 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.72404320 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.72048808 |
| 118 | MP0010630_abnormal_cardiac_muscle | 0.71424881 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.70971549 |
| 120 | MP0009931_abnormal_skin_appearance | 0.70643875 |
| 121 | MP0004087_abnormal_muscle_fiber | 0.70223089 |
| 122 | MP0003953_abnormal_hormone_level | 0.69526283 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.69518336 |
| 124 | MP0000566_synostosis | 0.69306839 |
| 125 | MP0005448_abnormal_energy_balance | 0.69290188 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.68450102 |
| 127 | MP0003283_abnormal_digestive_organ | 0.68002643 |
| 128 | MP0005330_cardiomyopathy | 0.66729101 |
| 129 | MP0005174_abnormal_tail_pigmentation | 0.66728273 |
| 130 | MP0002060_abnormal_skin_morphology | 0.66615826 |
| 131 | MP0005451_abnormal_body_composition | 0.66134001 |
| 132 | MP0002928_abnormal_bile_duct | 0.65172918 |
| 133 | MP0000579_abnormal_nail_morphology | 0.64474634 |
| 134 | MP0005379_endocrine/exocrine_gland_phen | 0.63609063 |
| 135 | MP0008469_abnormal_protein_level | 0.61993142 |
| 136 | MP0005376_homeostasis/metabolism_phenot | 0.60486484 |
| 137 | MP0001881_abnormal_mammary_gland | 0.59417786 |
| 138 | MP0001661_extended_life_span | 0.59058290 |
| 139 | MP0001765_abnormal_ion_homeostasis | 0.57617110 |
| 140 | MP0002971_abnormal_brown_adipose | 0.56996814 |
| 141 | MP0003329_amyloid_beta_deposits | 0.55200292 |
| 142 | MP0005187_abnormal_penis_morphology | 0.53454344 |
| 143 | MP0004130_abnormal_muscle_cell | 0.53192748 |
| 144 | MP0000613_abnormal_salivary_gland | 0.52371128 |
| 145 | MP0002896_abnormal_bone_mineralization | 0.52264673 |
| 146 | MP0005646_abnormal_pituitary_gland | 0.51825163 |
| 147 | MP0003959_abnormal_lean_body | 0.51018236 |
| 148 | MP0000230_abnormal_systemic_arterial | 0.49396108 |
| 149 | MP0000462_abnormal_digestive_system | 0.48113338 |
| 150 | MP0003638_abnormal_response/metabolism_ | 0.47537224 |
| 151 | MP0009384_cardiac_valve_regurgitation | 0.47364058 |
| 152 | MP0006054_spinal_hemorrhage | 0.47173505 |
| 153 | MP0008961_abnormal_basal_metabolism | 0.46362259 |
| 154 | MP0002098_abnormal_vibrissa_morphology | 0.45100542 |
| 155 | MP0009672_abnormal_birth_weight | 0.44616668 |
| 156 | MP0002970_abnormal_white_adipose | 0.41758246 |
| 157 | MP0002136_abnormal_kidney_physiology | 0.41562491 |
| 158 | MP0005266_abnormal_metabolism | 0.39848316 |
| 159 | MP0002135_abnormal_kidney_morphology | 0.39290890 |
| 160 | MP0008872_abnormal_physiological_respon | 0.38458444 |
| 161 | MP0001346_abnormal_lacrimal_gland | 0.36718890 |
| 162 | MP0002168_other_aberrant_phenotype | 0.35915742 |
| 163 | MP0005381_digestive/alimentary_phenotyp | 0.35086890 |
| 164 | MP0004782_abnormal_surfactant_physiolog | 0.31894411 |
| 165 | MP0005395_other_phenotype | 0.30012770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.05858369 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.56391931 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.31288063 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.77285192 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.67758334 |
| 6 | Xanthomatosis (HP:0000991) | 5.63932252 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.29169515 |
| 8 | Hypoglycemic coma (HP:0001325) | 5.24464073 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.63608431 |
| 10 | Ketosis (HP:0001946) | 4.46420716 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.41108320 |
| 12 | Complement deficiency (HP:0004431) | 4.39908045 |
| 13 | Hypoglycemic seizures (HP:0002173) | 4.16610979 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.16168312 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 4.12513550 |
| 16 | Hypochromic anemia (HP:0001931) | 4.07424130 |
| 17 | Abnormal hemoglobin (HP:0011902) | 4.04509672 |
| 18 | Hyperbilirubinemia (HP:0002904) | 4.03290677 |
| 19 | Hyperglycinemia (HP:0002154) | 3.90697724 |
| 20 | Poikilocytosis (HP:0004447) | 3.87339522 |
| 21 | Hyperammonemia (HP:0001987) | 3.85326845 |
| 22 | Ketoacidosis (HP:0001993) | 3.82224339 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.81050919 |
| 24 | Hypochromic microcytic anemia (HP:0004840) | 3.79481355 |
| 25 | Acanthocytosis (HP:0001927) | 3.79082338 |
| 26 | Fat malabsorption (HP:0002630) | 3.76197099 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.69026328 |
| 28 | Joint hemorrhage (HP:0005261) | 3.68731865 |
| 29 | Epidermoid cyst (HP:0200040) | 3.67486504 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.67436798 |
| 31 | Microcytic anemia (HP:0001935) | 3.65255287 |
| 32 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.61341148 |
| 33 | Protrusio acetabuli (HP:0003179) | 3.54905567 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.54790890 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.53856155 |
| 36 | Hyperglycinuria (HP:0003108) | 3.42960370 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.38638915 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.38638915 |
| 39 | Symptomatic seizures (HP:0011145) | 3.34973089 |
| 40 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.28279571 |
| 41 | Abnormality of methionine metabolism (HP:0010901) | 3.27666136 |
| 42 | Abnormal gallbladder morphology (HP:0012437) | 3.23862076 |
| 43 | Gingival bleeding (HP:0000225) | 3.23566629 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22396889 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.20509350 |
| 46 | Abnormality of complement system (HP:0005339) | 3.14592492 |
| 47 | Cholelithiasis (HP:0001081) | 3.13620317 |
| 48 | Peritonitis (HP:0002586) | 3.12555342 |
| 49 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.05157816 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 3.02544927 |
| 51 | Late onset (HP:0003584) | 2.98879204 |
| 52 | Gout (HP:0001997) | 2.91191157 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.88369957 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.86774324 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.82334810 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.81689859 |
| 57 | Arterial tortuosity (HP:0005116) | 2.81411406 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.79237431 |
| 59 | Toxemia of pregnancy (HP:0100603) | 2.78732808 |
| 60 | Reticulocytosis (HP:0001923) | 2.78203332 |
| 61 | Steatorrhea (HP:0002570) | 2.75579481 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75499786 |
| 63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.73743113 |
| 64 | Metabolic acidosis (HP:0001942) | 2.73704923 |
| 65 | Vascular tortuosity (HP:0004948) | 2.72546929 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 2.68932047 |
| 67 | Hyperglycemia (HP:0003074) | 2.68564054 |
| 68 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.68024496 |
| 69 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.63199245 |
| 70 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.63199245 |
| 71 | Abnormality of the gallbladder (HP:0005264) | 2.58527611 |
| 72 | Testicular neoplasm (HP:0010788) | 2.51729146 |
| 73 | Skin nodule (HP:0200036) | 2.51336201 |
| 74 | Flat acetabular roof (HP:0003180) | 2.49000537 |
| 75 | Irritability (HP:0000737) | 2.47856848 |
| 76 | Cholecystitis (HP:0001082) | 2.45878065 |
| 77 | Abnormal gallbladder physiology (HP:0012438) | 2.45878065 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41700804 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.40383810 |
| 80 | Vertebral compression fractures (HP:0002953) | 2.39066803 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.37185081 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.36639281 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36639281 |
| 84 | Myocardial infarction (HP:0001658) | 2.33046961 |
| 85 | Purpura (HP:0000979) | 2.33012861 |
| 86 | Exercise-induced myalgia (HP:0003738) | 2.30213148 |
| 87 | Lethargy (HP:0001254) | 2.26662813 |
| 88 | Spontaneous abortion (HP:0005268) | 2.26245454 |
| 89 | Brushfield spots (HP:0001088) | 2.25106019 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 2.17050032 |
| 91 | Abnormality of carpal bone ossification (HP:0006257) | 2.16265896 |
| 92 | Pancreatitis (HP:0001733) | 2.15941556 |
| 93 | Epistaxis (HP:0000421) | 2.15067274 |
| 94 | Esophageal varix (HP:0002040) | 2.13065520 |
| 95 | Cerebral aneurysm (HP:0004944) | 2.12331620 |
| 96 | Menorrhagia (HP:0000132) | 2.11595537 |
| 97 | Mitral stenosis (HP:0001718) | 2.11330100 |
| 98 | Glomerulonephritis (HP:0000099) | 2.10784497 |
| 99 | Abnormality of reticulocytes (HP:0004312) | 2.10708065 |
| 100 | Vomiting (HP:0002013) | 2.06759121 |
| 101 | Increased connective tissue (HP:0009025) | 2.06565274 |
| 102 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06482301 |
| 103 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06482301 |
| 104 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06482301 |
| 105 | Type 1 muscle fiber predominance (HP:0003803) | 2.06260610 |
| 106 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05872530 |
| 107 | Mucopolysacchariduria (HP:0008155) | 2.05872530 |
| 108 | Cervical subluxation (HP:0003308) | 2.05731021 |
| 109 | Polycythemia (HP:0001901) | 2.02714631 |
| 110 | Rickets (HP:0002748) | 2.02368814 |
| 111 | Neonatal onset (HP:0003623) | 2.00445302 |
| 112 | Ovoid vertebral bodies (HP:0003300) | 1.99548607 |
| 113 | Eczematoid dermatitis (HP:0000976) | 1.97998026 |
| 114 | Cerebral edema (HP:0002181) | 1.97994428 |
| 115 | Ocular albinism (HP:0001107) | 1.96946277 |
| 116 | Enlarged kidneys (HP:0000105) | 1.96393319 |
| 117 | Asymmetric septal hypertrophy (HP:0001670) | 1.96340774 |
| 118 | Myopathic facies (HP:0002058) | 1.94638283 |
| 119 | Acute hepatic failure (HP:0006554) | 1.93722383 |
| 120 | Abnormality of proline metabolism (HP:0010907) | 1.92939467 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.92939467 |
| 122 | Abnormality of the acetabulum (HP:0003170) | 1.92508124 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 1.92362128 |
| 124 | Sensorimotor neuropathy (HP:0007141) | 1.92115028 |
| 125 | Ulnar deviation of the wrist (HP:0003049) | 1.91918669 |
| 126 | Spastic diplegia (HP:0001264) | 1.91842323 |
| 127 | Back pain (HP:0003418) | 1.90309846 |
| 128 | Opisthotonus (HP:0002179) | 1.89471515 |
| 129 | Ileus (HP:0002595) | 1.88240928 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.86921178 |
| 131 | Malnutrition (HP:0004395) | 1.86694995 |
| 132 | Turricephaly (HP:0000262) | 1.86626387 |
| 133 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86197396 |
| 134 | Blue irides (HP:0000635) | 1.86165355 |
| 135 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86003891 |
| 136 | Bruising susceptibility (HP:0000978) | 1.85941588 |
| 137 | Cupped ribs (HP:0000887) | 1.85905790 |
| 138 | Broad palm (HP:0001169) | 1.85808899 |
| 139 | Aortic aneurysm (HP:0004942) | 1.85632609 |
| 140 | Metaphyseal cupping (HP:0003021) | 1.85217747 |
| 141 | Global brain atrophy (HP:0002283) | 1.83941801 |
| 142 | Systemic lupus erythematosus (HP:0002725) | 1.83762958 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.83131187 |
| 144 | Diaphragmatic weakness (HP:0009113) | 1.82702956 |
| 145 | Arthropathy (HP:0003040) | 1.82549529 |
| 146 | Protuberant abdomen (HP:0001538) | 1.81974998 |
| 147 | Coxa vara (HP:0002812) | 1.81612974 |
| 148 | Vascular calcification (HP:0004934) | 1.81550001 |
| 149 | Amyloidosis (HP:0011034) | 1.80895283 |
| 150 | Cerebral inclusion bodies (HP:0100314) | 1.80671617 |
| 151 | Germ cell neoplasia (HP:0100728) | 1.80564875 |
| 152 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.79411962 |
| 153 | Dysostosis multiplex (HP:0000943) | 1.79135898 |
| 154 | Difficulty running (HP:0009046) | 1.76574549 |
| 155 | Limb hypertonia (HP:0002509) | 1.74974513 |
| 156 | Osteomalacia (HP:0002749) | 1.74559876 |
| 157 | Increased serum ferritin (HP:0003281) | 1.72592468 |
| 158 | Orthostatic hypotension (HP:0001278) | 1.71976524 |
| 159 | Cardiovascular calcification (HP:0011915) | 1.71685540 |
| 160 | Abnormality of the peritoneum (HP:0002585) | 1.71361647 |
| 161 | Hyporeflexia of lower limbs (HP:0002600) | 1.71117357 |
| 162 | Atelectasis (HP:0100750) | 1.71091424 |
| 163 | Abnormal ossification of hand bones (HP:0005921) | 1.71086134 |
| 164 | Asymmetry of the thorax (HP:0001555) | 1.70524258 |
| 165 | Aneurysm (HP:0002617) | 1.69592222 |
| 166 | Flared iliac wings (HP:0002869) | 1.68434229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.90887294 |
| 2 | ERN1 | 4.87836937 |
| 3 | INSRR | 4.81204894 |
| 4 | SIK1 | 4.58005062 |
| 5 | TAOK3 | 3.24505196 |
| 6 | FGFR4 | 3.10858209 |
| 7 | MAP2K3 | 2.96989529 |
| 8 | TRIB3 | 2.91872781 |
| 9 | MAPK15 | 2.46319103 |
| 10 | ICK | 2.36349024 |
| 11 | NTRK1 | 2.24733515 |
| 12 | PRPF4B | 2.08974271 |
| 13 | SIK3 | 2.06317523 |
| 14 | FLT3 | 1.86729611 |
| 15 | EEF2K | 1.81499876 |
| 16 | FRK | 1.81495942 |
| 17 | TAOK1 | 1.80679950 |
| 18 | MAP3K2 | 1.66473264 |
| 19 | TAOK2 | 1.62049725 |
| 20 | IRAK2 | 1.61512620 |
| 21 | EPHB2 | 1.59765512 |
| 22 | MAPK11 | 1.53337978 |
| 23 | PKN2 | 1.52888544 |
| 24 | PTK6 | 1.52199103 |
| 25 | WNK1 | 1.48128363 |
| 26 | ERBB2 | 1.41908367 |
| 27 | PASK | 1.41673427 |
| 28 | RIPK4 | 1.38854294 |
| 29 | ERBB4 | 1.37470736 |
| 30 | LATS1 | 1.34123140 |
| 31 | TTN | 1.33647193 |
| 32 | PTK2B | 1.32180404 |
| 33 | KSR1 | 1.31820686 |
| 34 | TRPM7 | 1.30640683 |
| 35 | CDK12 | 1.27637997 |
| 36 | MAP3K6 | 1.27627554 |
| 37 | DYRK1B | 1.21925299 |
| 38 | MAP3K10 | 1.21391461 |
| 39 | FGR | 1.19376204 |
| 40 | STK38 | 1.19156364 |
| 41 | PDGFRA | 1.17578181 |
| 42 | MARK2 | 1.16453029 |
| 43 | JAK2 | 1.16171660 |
| 44 | PTK2 | 1.15857027 |
| 45 | MET | 1.15139904 |
| 46 | TNK2 | 1.09541346 |
| 47 | MAP2K2 | 1.07524472 |
| 48 | IRAK1 | 1.07144087 |
| 49 | OBSCN | 1.05377675 |
| 50 | PIK3CG | 1.04444993 |
| 51 | FGFR2 | 1.02641097 |
| 52 | MAP2K4 | 1.01420079 |
| 53 | MST1R | 1.00879708 |
| 54 | EPHA3 | 0.92446776 |
| 55 | HIPK2 | 0.92173618 |
| 56 | DMPK | 0.91523240 |
| 57 | RET | 0.88655942 |
| 58 | EIF2AK3 | 0.88508166 |
| 59 | PDPK1 | 0.87287572 |
| 60 | TYK2 | 0.85517410 |
| 61 | ZAP70 | 0.84312683 |
| 62 | TGFBR2 | 0.83685508 |
| 63 | IRAK3 | 0.82867560 |
| 64 | PIK3CA | 0.81395428 |
| 65 | SMG1 | 0.79833854 |
| 66 | MARK3 | 0.78964944 |
| 67 | RPS6KA2 | 0.78455298 |
| 68 | CSK | 0.78397093 |
| 69 | PRKAA1 | 0.75750329 |
| 70 | PRKCZ | 0.75454256 |
| 71 | MAP2K1 | 0.75315891 |
| 72 | DAPK2 | 0.73234516 |
| 73 | MAP3K1 | 0.73179313 |
| 74 | GRK5 | 0.72104521 |
| 75 | CAMK1D | 0.70526581 |
| 76 | MAP3K7 | 0.70014736 |
| 77 | MAP3K3 | 0.69985170 |
| 78 | MAPK12 | 0.69741092 |
| 79 | STK4 | 0.68015696 |
| 80 | PRKAA2 | 0.67985204 |
| 81 | PRKACG | 0.66701244 |
| 82 | ABL2 | 0.66683509 |
| 83 | SGK3 | 0.66569860 |
| 84 | FER | 0.65796006 |
| 85 | BCR | 0.65541525 |
| 86 | YES1 | 0.65372666 |
| 87 | GRK6 | 0.64873737 |
| 88 | CHUK | 0.64831061 |
| 89 | NEK9 | 0.64132377 |
| 90 | MAPKAPK3 | 0.64111341 |
| 91 | WNK4 | 0.62300667 |
| 92 | SGK1 | 0.62284596 |
| 93 | MTOR | 0.61792829 |
| 94 | KDR | 0.60948119 |
| 95 | JAK1 | 0.60833204 |
| 96 | TYRO3 | 0.58580768 |
| 97 | DDR2 | 0.57965829 |
| 98 | GSK3A | 0.57806471 |
| 99 | PAK3 | 0.56811714 |
| 100 | EIF2AK1 | 0.56635520 |
| 101 | BMX | 0.54653284 |
| 102 | PRKD3 | 0.54554759 |
| 103 | PDK1 | 0.54351082 |
| 104 | RPS6KL1 | 0.52664247 |
| 105 | RPS6KC1 | 0.52664247 |
| 106 | RAF1 | 0.52095316 |
| 107 | SCYL2 | 0.51820520 |
| 108 | DYRK3 | 0.50010099 |
| 109 | CDK6 | 0.48845750 |
| 110 | MAP3K5 | 0.47887631 |
| 111 | SGK2 | 0.47083773 |
| 112 | AKT3 | 0.46733973 |
| 113 | SGK223 | 0.45850613 |
| 114 | SGK494 | 0.45850613 |
| 115 | HCK | 0.45340659 |
| 116 | RIPK1 | 0.42665306 |
| 117 | PRKD1 | 0.42014710 |
| 118 | PDGFRB | 0.41476788 |
| 119 | CAMK1G | 0.41338137 |
| 120 | MAPKAPK2 | 0.40130593 |
| 121 | TBK1 | 0.40077847 |
| 122 | IGF1R | 0.39671453 |
| 123 | LMTK2 | 0.39237352 |
| 124 | RPS6KA6 | 0.37232036 |
| 125 | PIM1 | 0.36881231 |
| 126 | PRKCH | 0.36020197 |
| 127 | JAK3 | 0.35220554 |
| 128 | MYLK | 0.35029235 |
| 129 | MATK | 0.33787644 |
| 130 | EGFR | 0.33294997 |
| 131 | CDC42BPA | 0.30150344 |
| 132 | MAP3K11 | 0.26840104 |
| 133 | BRSK1 | 0.25979187 |
| 134 | EPHB1 | 0.25880434 |
| 135 | PRKCQ | 0.25019787 |
| 136 | CSNK1A1 | 0.24381217 |
| 137 | FGFR3 | 0.24374589 |
| 138 | PINK1 | 0.23169936 |
| 139 | GRK1 | 0.22721994 |
| 140 | KSR2 | 0.22287566 |
| 141 | FGFR1 | 0.19189158 |
| 142 | PRKD2 | 0.18992188 |
| 143 | NUAK1 | 0.18747474 |
| 144 | LRRK2 | 0.18466594 |
| 145 | MAPK3 | 0.18246748 |
| 146 | RPS6KB1 | 0.18197461 |
| 147 | NTRK2 | 0.17689095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.18507829 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.58188843 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.06268225 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.89714637 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.85437890 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83719749 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66996869 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55865865 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.55195918 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53006562 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.51857977 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.49880230 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48541468 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20417333 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.18429602 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.97970961 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96810347 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96637698 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92178170 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.91364555 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87934457 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83617897 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.83209089 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.74552504 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73330780 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65533011 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65471493 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.64669467 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.62642385 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62311538 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61413695 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57493832 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50787517 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50278182 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50201224 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49528434 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49519159 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.48235878 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.42413917 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41603682 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.39392987 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38642823 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.37796084 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.37641850 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34968826 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33067162 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31484169 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31351126 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 1.31287553 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23889050 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23767748 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.21953059 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.16080590 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14092996 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08119092 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.06296531 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01766358 |
| 58 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01572783 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98458315 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97104783 |
| 61 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.96592036 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96516710 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.96321377 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95496154 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95461675 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95149855 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91394924 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.89723384 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89229377 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81763260 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81363906 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.80924941 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79365855 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78523636 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.78284536 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77233406 |
| 77 | Protein export_Homo sapiens_hsa03060 | 0.77122196 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76198247 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74631489 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71899188 |
| 81 | Prostate cancer_Homo sapiens_hsa05215 | 0.71264067 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70196824 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.69233300 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.69108508 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67047685 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66628351 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.66402584 |
| 88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66204530 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65937037 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65827335 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65634774 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65630618 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64140496 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.64065908 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62346708 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.59037844 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57149757 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57046207 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56723914 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56559929 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.55785763 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55202768 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54618868 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54544237 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51516891 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51037301 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.48681003 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47993265 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47058174 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.46392461 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46206498 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45608908 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42876314 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.40079967 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35154707 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31401603 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31273379 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30795161 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26370219 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21573252 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20366233 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20201426 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19562419 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19075148 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.18396059 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.17616506 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15872776 |
| 128 | Insulin secretion_Homo sapiens_hsa04911 | 0.13968946 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13281693 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.12773044 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12137819 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10428067 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.09573790 |
| 134 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.07968822 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02384873 |
| 136 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.01845203 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.01046415 |
| 138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0308707 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0296929 |
| 140 | Cocaine addiction_Homo sapiens_hsa05030 | -0.0113153 |
| 141 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0102611 |
| 142 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0025176 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0023156 |

